首页> 外国专利> Analysis of HIV-1 coreceptor use in the clinical care of HIV-1-infected patients

Analysis of HIV-1 coreceptor use in the clinical care of HIV-1-infected patients

机译:在HIV-1感染患者的临床护理中使用HIV-1共受体的分析

摘要

A change in viral tropism occurs in many HIV positive individuals over time and can be indicated by a shift in coreceptor use from CCR5 to CXCR4. The shift in coreceptor use to CXCR4 has been shown to correlate with increased disease progression. In patients undergoing HAART, the predominant populations of virus can be shifted back to CCR5-mediated entry after the CXCR4-specific strains have emerged. The present invention relates to a diagnostic method to monitor coreceptor use in the treatment of human immunodeficiency virus (HIV) infection. The present invention further relates to a diagnostic method applied to HIV-positive individuals undergoing HAART to monitor the suppression of CXCR4 specific strains. The diagnostic methods can be used to assist in selecting antiretroviral therapy and to improve predictions of disease prognosis over time.
机译:随着时间的流逝,许多HIV阳性个体会发生病毒向性变化,这可以通过共受体的使用从CCR5转换为CXCR4来表明。已显示共受体向CXCR4的使用与疾病进展增加相关。在接受HAART的患者中,在出现CXCR4特异性菌株后,主要的病毒群体可以转移回CCR5介导的进入。本发明涉及一种诊断方法,以监测共受体在治疗人免疫缺陷病毒(HIV)感染中的用途。本发明进一步涉及一种诊断方法,其应用于经历HAART以监测CXCR4特异性菌株的抑制的HIV阳性个体。诊断方法可用于协助选择抗逆转录病毒疗法,并随着时间的推移改善疾病预后的预测。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号